25国儿童哮喘、花粉症与湿疹负担:GAN第一阶段研究
结果显示哮喘、鼻结膜炎和湿疹症状现患率分别为11.0%/9.1%、13.3%/7.7%和6.4%/5.9%;中低收入国家症状患病率较低但负担仍显著。
要点
- 青少年哮喘现患率11.0%,儿童9.1%;鼻结膜炎青少年13.3%、儿童7.7%。
- 中低收入国家三种疾病症状患病率显著较低,但负担仍相当可观。
- 中心间变异占所有疾病症状变异的10-20%,提示地域差异明显。
核心结论
- 哮喘、鼻结膜炎和湿疹负担在有限研究国家间差异很大,中低收入国家症状患病率较低但负担仍显著。
主要发现
- 青少年与儿童哮喘症状现患率分别为11.0%和9.1%,鼻结膜炎为13.3%和7.7%,湿疹为6.4%和5.9%。
- 青少年与儿童哮喘终生患病率分别为10.5%和7.6%,花粉症终生患病率为15.2%和11.1%,湿疹终生患病率为10.6%和13.4%。
- 低或中低收入国家中心三种疾病症状和诊断(花粉症除外)患病率显著较低。
- 儿童中男孩哮喘和鼻结膜炎症状患病率较高,青少年中则相反;女性青少年湿疹患病率为男性两倍,儿童中无性别差异。
- 中心间变异占所有疾病症状变异的10-20%。
临床怎么用
- 提示呼吸科医生应关注儿童及青少年哮喘与鼻结膜炎的标准化患病率数据,用于评估区域负担。
局限性
- 研究仅覆盖有限数量国家,中心间变异较大,可能影响结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: There have been no worldwide standardised surveys of prevalence and severity of asthma, rhinoconjunctivitis and eczema in school children for 15 years. The present study aims to provide this information. METHODS: Following the exact International Study of Asthma and Allergies in Childhood (ISAAC) methodology (cross-sectional questionnaire-based survey), Global Asthma Network (GAN) Phase I was carried out between 2015 and 2020 in many centres worldwide. RESULTS: The study included 157 784 adolescents (13-14 years of age) in 63 centres in 25 countries and 101 777 children (6-7 years of age) in 44 centres in 16 countries. The current prevalence of symptoms, respectively, was 11.0% and 9.1% for asthma, 13.3% and 7.7% for rhinoconjunctivitis and 6.4% and 5.9% for eczema. The prevalence of asthma ever was 10.5% and 7.6%, hay fever ever was 15.2% and 11.1% and eczema ever was 10.6% and 13.4%, respectively. Centres in low or lower middle gross national income countries (LICs or LMICs) had significantly lower prevalence of the three disease symptoms and diagnoses (except for hay fever). In children, the prevalence of asthma and rhinoconjunctivitis symptoms was higher in boys, while the reverse occurred among adolescents. For eczema, while the prevalence among female adolescents was double that of males, there was no sex difference among children. Centre accounted for non-negligible variability in all disease symptoms (10-20%). CONCLUSION: The burdens of asthma, rhinoconjunctivitis and eczema vary widely among the limited number of countries studied. Although symptom prevalence is lower in LICs and LMICs, it represents a considerable burden everywhere studied.
引用
- García-Marcos L, Asher MI, Pearce N, et al. The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study. Eur Respir J. 2022. PMID: 35144987. doi:10.1183/13993003.02866-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。